Massive Bio
500 Global 2016 · Developer of an artificial intelligence-driven platform intended to connect cancer patients to biopharmaceutical clinical trials.
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Active | YCW25 | |
| Other | Not stated | 500 GlobalGA 18 | |
| AI | Active | YCW23 | |
| AI | Not stated | EF2025 | |
| Other | Not stated | EF2019 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Not stated | Antler2026 | |
| Vine HealthShared: cancer patient, healthcareNot statedOther | Other | Not stated | EF2019 |
| Other | Active | YCW23 | |
| AI | Not stated | Plug and Play | |
| Other | Not stated | SPC2021 |
Also from 500 Global in AI
All of 500 GlobalPrograms
| Program | Cohort | Source |
|---|---|---|
| 2016 | 500 Global Page |
About Massive Bio
Developer of an artificial intelligence-driven platform intended to connect cancer patients to biopharmaceutical clinical trials. The company offers tech-enabled services and a big data platform that addresses the clinical trial enrollment value chain by providing patient identification, pre-screening, and concierge enrollment enablement while being focused on oncology and innovative data, technology, and services, enabling patients to get an effective treatment without disrupting lives and becoming a financial hindrance.
- Category
- AI
- Location
- United States
- Checked
- 1h ago
Tags: Health Tech, Healthcare
Massive Bio: questions
Which accelerators did Massive Bio go through?
Massive Bio is listed by 500 Global (Global 2016).
Where is Massive Bio based?
Massive Bio lists United States as its location on 500 Global's page.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.